Dimed S.a. Distribuidora De MedicamentosBMFBOVESPA: PNVL3

Dimed: Strong revenue and profit growth, digital expansion, and market share gains in 1Q26

· Issued by Dimed S.a. Distribuidora De Medicamentos

Retail gross revenue grew 15.1% year-over-year, with adjusted EBITDA up 25.6% and net income up 38.1%. Digital sales rose to 28.5% of revenue, and market share in the South reached 13.3%. Guidance targets continued expansion and margin improvement.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Dimed S.a. Distribuidora De Medicamentos

All Dimed S.a. Distribuidora De Medicamentos news releases